Health Care :: Investment in care home sector – Scotland
The care home sector is set to benefit from a ?30 million injection to increase care home fees, it was announced on 17/11/2006 in Scotland.
Care
Dementia :: Alzheimer’s drugs ban in UK, NHS – NICE
National Institute for Clinical Excellence (NICE) has restricted the use of Alzheimer’s drugs in the National Health Service, recently.
Smoking :: Passive smoking causes chronic lung troubles, affecting healthy
Passive smoking does cause respiratory troubles in healthy adults, a new study confirms. The study is in the November issue of the American Journal of Respiratory and Critical Care Medicine.
Asthma :: GlaxoSmithKline welcomes new GINA guidelines for Asthma Management and Prevention
GlaxoSmithKline (GSK) today welcomes new guidelines for Asthma Management and Prevention released today from The Global Initiative for Asthma (GINA). The guidelines emphasise that the overall aim of asthma treatment is to achieve and maintain long-term control of the disease and introduce a new classification of asthma based on levels of control1. Recommended treatment action is then based on the patient?s level of control.
Fungal Infections :: Novartis’ Mycograb might be approved in Europe for serious fungal infections
Novartis announced today that it plans to submit additional information to the Committee for Medicinal Products for Human Use (CHMP) in Europe to support the approval of Mycograb?, in development as a treatment for life-threatening fungal infections, after the CHMP issued a negative recommendation.
Fosrenol data show evidence of trends towards improved bone formation in CKD stage 5 patients
Treatment with the phosphate binder FOSRENOL(R) (lanthanum carbonate) was associated with slight improvements in bone formation in chronic kidney disease (CKD) Stage 5 patients with hyperphosphatemia (high phosphorus levels in the blood), according to long-term (two-year) data presented at the American Society of Nephrology (ASN) meeting. Additional studies presented at ASN document the efficacy and safety of the reformulated and higher-dose FOSRENOL tablets.
New study shows Actonel almost halves the risk of hip fractures compared to alendronate
Data published today from a retrospective study of over 33,000 postmenopausal women showed that among patients newly prescribed one of the two most popular osteoporosis treatments, patients taking Actonel? (risedronate sodium) were approximately half as likely to sustain a hip fracture as those taking alendronate in the first year of treatment. These results were published today in the peer-reviewed journal Osteoporosis International.1
Exercise helps elderly regain physical function and avoid major disability
Regular structured exercise may allow previously sedentary elderly people to attain significant improvements in their physical functioning and reduce the likelihood they will become disabled in the future, according to findings from a multicenter pilot study being presented today at the Gerontological Society of America’s annual meeting in Dallas.
DNA :: Mayo Clinic – Gene expression profiling not quite perfected in predicting lung cancer prognosis
While there have been significant advances in the use of gene expression profiling to assess a cancer prognosis, a Mayo Clinic review and analysis of existing lung cancer studies shows that this technology has not yet surpassed the accuracy of conventional methods used to assess survival in lung cancer patients.
Dementia :: Occupational Therapy Improves Quality of Life for Dementia Patients and Their Carers
Occupational therapy can help to improve the ability of people with dementia patients to perform daily activities and can also reduce the pressure on their caregivers, says a BMJ study published today.